We are live on ! Find out more
ALNA

Allena Pharmaceuticals
ALNA

Delisted

ALNA was delisted on the 7th of September, 2022.

Back to rankings

40 hedge funds and large institutions have $158M invested in Allena Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 40 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
40
Holders Change
+40
Holders Change %
–
% of All Funds
0.91%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.11%
New
40
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FM
Frazier Management
Washington
+$41M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$32.4M
3
DVC
Deer VII & Co
New York
+$27.9M
4
PHS
PFM Health Sciences
California
+$18M
5
PI
Pharmstandard International
Luxembourg
+$12.8M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
FM
1
Frazier Management
Washington
$33.5M +$41M +3,330,373 New
TGI
2
TRV GP II
Massachusetts
$28.1M +$34.4M +2,790,964 New
Fidelity Investments
3
Fidelity Investments
Massachusetts
$24.7M +$32.4M +2,631,252 New
DVC
4
Deer VII & Co
New York
$20.5M +$27.9M +2,263,365 New
PHS
5
PFM Health Sciences
California
$13.3M +$18M +1,464,204 New
Wellington Management Group
6
Wellington Management Group
Massachusetts
$7.62M +$9.34M +757,683 New
DM
7
Deerfield Management
New York
$6.09M +$7.46M +605,100 New
PIM
8
Partner Investment Management
California
$4.72M +$7.09M +575,407 New
Morgan Stanley
9
Morgan Stanley
New York
$3.76M +$4.61M +373,985 New
JP Morgan Chase
10
JP Morgan Chase
New York
$3.6M +$4.41M +357,843 New
SFM
11
Sphera Funds Management
Israel
$3.27M +$4.01M +325,000 New
PA
12
Perceptive Advisors
New York
$2.52M +$3.08M +250,000 New
BlackRock
13
BlackRock
New York
$2.28M +$2.79M +226,775 New
Vanguard Group
14
Vanguard Group
Pennsylvania
$1.87M +$2.29M +186,193 New
Northern Trust
15
Northern Trust
Illinois
$591K +$724K +58,743 New
Goldman Sachs
16
Goldman Sachs
New York
$499K +$612K +49,643 New
NIM
17
Needham Investment Management
New York
$259K +$225K +18,288 New
Millennium Management
18
Millennium Management
New York
$225K +$276K +22,356 New
Deutsche Bank
19
Deutsche Bank
Germany
$118K +$146K +11,846 New
DIM
20
DC Investments Management
Virginia
$116K +$143K +11,568 New
Bank of New York Mellon
21
Bank of New York Mellon
New York
$102K +$125K +10,182 New
California State Teachers Retirement System (CalSTRS)
22
California State Teachers Retirement System (CalSTRS)
California
$85K +$105K +8,495 New
TCIM
23
TIAA CREF Investment Management
New York
$77K +$93.8K +7,613 New
New York State Common Retirement Fund
24
New York State Common Retirement Fund
New York
$67K +$82.6K +6,700 New
TA
25
Teachers Advisors
New York
$62K +$76.3K +6,190 New
1
2

ALNA Hedge Fund Activity: Q4 2017 in Review

40 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Allena Pharmaceuticals (ALNA) for Q4 2017, worth a combined $158M.

Buyers outnumbered sellers: 40 funds opened new ALNA positions and 0 closed out — a net gain of 40 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Frazier Management, opening a new position worth an estimated $41M.

  • 40 institutional investors held Allena Pharmaceuticals (ALNA) as of Q4 2017, up from 0 in Q3 2017.
  • Funds reported $158M of Allena Pharmaceuticals stock for Q4 2017.
  • 40 funds opened new Allena Pharmaceuticals positions in Q4 2017 and 0 closed out, a net change of +40 holders.
  • The largest Allena Pharmaceuticals buyer in Q4 2017 was Frazier Management, an estimated $41M added.

Based on aggregated 13F filings for Q4 2017.